Polly A. Murphy serves as Executive at Atea Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Polly A. Murphy has executed 4 insider transactions totaling $151.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 16, 2024 involved exercising options for 33,150 shares valued at $0.
Polly A. Murphy currently holds 56,445 shares of Atea Pharmaceuticals, Inc. (AVIR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Polly A. Murphy has been a net buyer of AVIR stock. They have purchased $151.2K and sold $0 worth of shares.
Polly A. Murphy's most recent insider trade was on Jun 16, 2024, when they sold 33,150 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $9.68 |
| Discretionary |
| Dec 20, 2021 | AVIR | $102.8K | Purchase | 12,000 | $8.57 | Discretionary |
| Nov 3, 2020 | AVIR | $0 | Conversion | 11,295 | $N/A | Discretionary |